Navigation Links
BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property
Date:7/28/2011

Medicinal Nanoengineering® platform to develop and commercialize our best-in-class targeted therapeutics."

Alan D. Gold, Chairman and Chief Executive Officer of BioMed, remarked, "We welcome BIND Biosciences to Vassar Street and the vibrant Cambridgeport life science submarket. The company's co-founders and leaders, Dr. Robert Langer of MIT, Dr. Omid Farokhzad of Harvard, and Scott Minick, CEO, have quickly positioned BIND as a leader in the emerging field of nanomedicine. The newly redeveloped and redesigned Vassar Street facility will be the ideal home for BIND to pursue its pioneering research in nanomedicine and deploy their proprietary Medicinal Nanoengineerin® platform to accelerate targeted drug development."

About BIND Biosciences

BIND Biosciences, Inc. is a biopharmaceutical company leveraging its proprietary Medicinal Nanoengineering® platform to produce best in class drugs. BIND's platform enables the design, engineering and manufacturing of targeted nanoparticle therapeutics with unprecedented control over drug PK, biodistribution and cell- or tissue-specific targeting. Medicinal Nanoengineering complements medicinal chemistry to enable predictable, cost effective, and rapid development of breakthrough products with superior efficacy and safety profiles. Product opportunities include enabling or expediting the development of pipeline molecules as well as improving performance, expanding indications, or life cycle extension for mid- and late-stage products. BIND's initial product development efforts are in the areas of oncology, inflammatory diseases and cardiovascular disorders. BIND's lead program, BIND-014, targets a surface protein upregulated in a broad range of solid tumors.  BIND-014 is currently undergoing Phase I clinical testing in cancer patients.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate
'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
2. Regenesis Biomedical Announces Additions to Board of Directors
3. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
4. Plexus Systems, Inc. to Exhibit at BIOMEDevice Medical Technology Conference
5. Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research
6. BioMed Realty Trust Declares Third Quarter 2008 Common Stock and Preferred Stock Dividends
7. BioMed Realty Trust Announces Exercise of Over-Allotment Option
8. Isilon CTO Addresses Life Science Data Storage Challenges at Harvard Medical Schools BioMedical HPC Leadership Summit
9. BioMed Realty Trust Announces 36,900 Square Foot Lease in Seattle With Novo Nordisk
10. Balan Biomedical, Inc. Announces the Formation of Battery Consulting Group
11. Environmental Tectonics Corporations BioMedical Systems Division Places Two Monoplace Chambers at East Orange (NJ) General Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... August 01, 2014 This is a ... the Ammonium Bicarbonate industry in Global and China. The ... definitions, applications and industry chain structure. Global market analysis ... focus on history, developments, trends and competitive landscape of ... situation is also offered. , The report also focuses ...
(Date:8/1/2014)... CHICAGO , Aug. 1, 2014 AACC, ... better health through laboratory medicine, unveiled an updated brand ... laboratory professionals adapt to the changing healthcare environment and ... insight to physicians, so patients get the care they ... make up AACC,s membership play an essential role in ...
(Date:8/1/2014)... Aug. 1, 2014 Research and Markets ... Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Single Nucleotide Polymorphism (SNP) ... of SNPs in the genome of various species. SNPs ... genotyping and analysis technology can analyze thousands of SNPs ...
(Date:8/1/2014)... Glencoe Software, Inc. is pleased ... ( http://glencoesoftware.com/data-inpress.html ), a suite of data ... into on-line publications.  The suite comprises Glencoe ... Photo - http://photos.prnewswire.com/prnh/20140731/132410   ... The DataViewer is a browser-based ...
Breaking Biology Technology:Ammonium Bicarbonate Market in Internations & Chinese Regions Research Analysis Now Available at DeepResearchReports.com 2Ammonium Bicarbonate Market in Internations & Chinese Regions Research Analysis Now Available at DeepResearchReports.com 3AACC Debuts Refreshed Brand Identity 2Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018 2Glencoe Software Launches Data InPress 2Glencoe Software Launches Data InPress 3
... 25 Tengion Inc., a clinical stage regenerative medicine company focused ... Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present ... 2, 2008 at 9:50 a.m. EST at The Palace Hotel in ... About Tengion , , ...
... RICHMOND, Va., Nov. 25 Insmed Inc. (Nasdaq: ... today that Dr. Geoffrey Allan, President and CEO of Insmed, ... View Conference on December 3, 2008, in New York. , ... conference is to better educate the investment community on the ...
... (Nasdaq: IDEV ) today announced its consolidated results,of ... September,30, 2008. The Company will host a conference call ... below). , The Company ... 18% from fiscal 2007 revenues of $66.1 million. For ...
Cached Biology Technology:Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference 2Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 2Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 3Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 4Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 5Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 6Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 7Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 8Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 9Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 10Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 11
(Date:7/31/2014)... study of bigeye tuna movements in the northwestern Atlantic ... Pelagics Research Center at the University of Massachusetts Amherst, ... wide geographical range with pronounced north-south movements from Georges ... high-use area off Cape Hatteras southwest of Bermuda for ... approach to study one of the most important commercial ...
(Date:7/31/2014)... tracing nearly 3,000 genes to the earliest common ... scientists have created an extensive "Tree of Lepidoptera" ... DNA sequencing. , Among the study,s more ... small moths than to large ones, which completely ... study also found that some insects once classified ...
(Date:7/31/2014)... that biomass burning burning forests to create ... slash-and-burn agriculture and wildfires figures into both ... the release of a new study by Stanford ... Jacobson, the degree of that contribution had never ... a paper published July 30 in the ...
Breaking Biology News(10 mins):Study of bigeye tuna in Northwest Atlantic uses new tracking methods 2Study of bigeye tuna in Northwest Atlantic uses new tracking methods 3UF study advances 'DNA revolution,' tells butterflies' evolutionary history 2UF study advances 'DNA revolution,' tells butterflies' evolutionary history 3Stanford professor finds that wildfires and other burns play bigger role in climate change 2Stanford professor finds that wildfires and other burns play bigger role in climate change 3Stanford professor finds that wildfires and other burns play bigger role in climate change 4
... steady rise in autoimmune diseases such as multiple sclerosis ... factors could be the cause of this increase. One ... excessively germ-free environment may contribute to an increase in ... play a role in increasing autoimmune disease incidence. The ...
... a chronic relapsing inflammatory disorder of the intestinal ... in the developed world. Common symptoms include abdominal ... associated with debilitating clinical complications. Researchers from the ... important clue to the susceptibility of individuals to ...
... shown that termites can tell what sort of material their ... The findings may lead to improvements in the control of ... wooden blocks and specially designed blocks made of wood and ... the blocks containing the most wood ?even though they could ...
Cached Biology News:Parasite infection may benefit MS patients 2
Mouse monoclonal [M7-PB-E9] to pan alpha Sodium Potassium ATPase ( Abpromise for all tested applications)....
Anti-Cohesin (Scc1/Rad21) Monoclonal Antibody Research Focus: signal transduction Storage: -20C Shipping Temperature: +4C...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
E2F2 protein...
Biology Products: